Stock data
Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (BMY) reported revenue of US$48.19B and net income of US$7.05B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$48.19B | — | — | US$7.05B | — |
| 2024 | US$48.30B | — | — | -US$8.95B | — |
| 2023 | US$45.01B | — | — | US$8.03B | — |
| 2022 | US$46.16B | — | — | US$6.33B | — |
| 2021 | US$46.38B | — | — | US$6.99B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$12.97B | US$3.32B | — |
| 2026-03-31 | US$11.49B | US$2.68B | — |
| 2025-12-31 | US$12.50B | US$1.09B | — |
| 2025-09-30 | US$12.22B | US$2.20B | — |
| 2025-06-30 | US$12.27B | US$1.31B | — |
| 2025-03-31 | US$11.20B | US$2.46B | — |
| 2024-12-31 | US$12.34B | US$72.00M | — |
| 2024-09-30 | US$11.89B | US$1.21B | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.